This is good news! A Covid-19 treatment drug developed by a Singapore-based firm Tychan enters its final trial phase. While many vaccines are being developed and entering final phases of clinical trials, it is great to know that a treatment drug is also entering its final trial phase. This will certainly help those who are already infected even as infections around the world continue to surge.
Apparently, this particular drug known as TY027 is effective on patients in the first 7 days of infection. The are few side effects. Let’s hope this trial will be successful and the drug can be approved for use early next year.